Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy
Fabio MazzolaniPrivate Practice, Milan, ItalyBackground: The purpose of this open-label study was to investigate the effect of a curcumin-phospholipid (lecithin, Meriva®) formulation (Norflo® tablet) on visual acuity and retinal thickness in patients with acute or chronic cen...
Guardado en:
Autor principal: | Mazzolani F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/58d75bbf3e204cec8b374bbd77705fcf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study
por: Mazzolani F, et al.
Publicado: (2013) -
Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy
por: Chin EK, et al.
Publicado: (2015) -
Low-dose aspirin as treatment for central serous chorioretinopathy
por: Antonio Caccavale, et al.
Publicado: (2010) -
Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
por: Karim SP, et al.
Publicado: (2013) -
Transpupillary thermotherapy for atypical central serous chorioretinopathy
por: Kawamura R, et al.
Publicado: (2012)